Search Within

Kamal Nand Menghrajani

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (7)
  3. Research Letter (2)
Groups
  1. Adult Leukemia (23)
  2. Biostatistics Service (23)
  3. Center for Hematologic Malignancies (23)
  4. Department of Medicine (23)
  5. Epidemiology and Biostatistics (23)
  6. Hematologic Malignancies, Division of (23)

More Groups

People
  1. Sean Devlin (17)
  2. Martin Tallman (15)
  3. Christopher Famulare (14)
  4. Jacob Glass (14)
  5. Ross Levine (14)
  6. Aaron Goldberg (13)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (4)
  5. 2020 (7)
  6. 2019 (5)

More Years

Publications
  1. Blood (13)
  2. American Journal of Hematology (2)
  3. Blood Advances (2)
  4. Biology of Blood and Marrow Transplantation (1)
  5. Haematologica (1)
  6. Leukemia Research (1)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. John Wiley & Sons, Inc. (2)
  3. Nature Publishing Group (2)
  4. Elsevier Inc. (1)
  5. Elsevier Ltd (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
    Meeting Abstract

    Gao, T.; Ptashkin, R.; Bolton, K. L.; Fong, C.; Spitzer, B.; Menghrajani, K.; Arango Ossa, J. E.; Zhou, Y.; Bernard, E.; Levine, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
    Research Letter

    Bernard, E.; Nannya, Y.; Hasserjian, R. P.; Devlin, S. M.; Tuechler, H.; Medina-Martinez, J. S.; Yoshizato, T.; Shiozawa, Y.; Saiki, R.; Malcovati, L.; more...
    Nature Medicine (2020)

    Fulltext@MSK | Save
  • Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomes
    Journal Article

    Menghrajani, K.; Zhang, Y.; Famulare, C.; Devlin, S. M.; Tallman, M. S.
    Leukemia Research (2020)

    Fulltext@MSK | Save
  • MLL-rearranged AML is associated with poor outcomes as compared to patients with intermediate- and adverse-risk disease: A CIBMTR study of 3779 adult patients
    Meeting Abstract

    Menghrajani, K.; Zhang, M. J.; Bo-Subait, K.; Wang, H. L.; Devlin, S. M.; Madero-Marroquin, R.; Gomez Arteaga, A.; Sandmaier, B. M.; Litzow, M. R.; Kebriaei, P.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • A phase Ib/II study of the histone methyltransferase inhibitor pinometostat in combination with azacitidine in patients with 11q23-rearranged acute myeloid leukemia
    Meeting Abstract

    Menghrajani, K.; Cai, S. F.; Devlin, S. M.; Armstrong, S. A.; Piekarz, R.; Rudek, M.; Tallman, M. S.; Stein, E. M.
    Blood (2019)

    Fulltext@MSK | Save
  • TP53 state dictates genome stability, clinical presentation and outcomes in myelodysplastic syndromes
    Meeting Abstract

    Bernard, E.; Nannya, Y.; Yoshizato, T.; Hasserjian, R. P.; Saiki, R.; Shiozawa, Y.; Devlin, S. M.; Tuechler, H.; Sarian, A.; Malcovati, L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save